Research Scope
LIH aims to perform research that transcends the classical boundaries of individual diseases and that can be tangibly applied in the clinical practice to address unmet needs, thus positively affecting health outcomes for patients. In other words, precision medicine.
At LIH, novel diagnostic, curative and preventive approaches are developed in a multidisciplinary manner, leveraging the institute’s expertise ranging from ‘omic’ approaches to public health epidemiology, exposure measurement and digital health.
The institute’s research activities put the patient at the center and aim to fully embrace the current paradigm shift in biomedical research, driven by the widespread adoption of disruptive technologies such as big data, artificial intelligence and machine learning. LIH’s research revolves around the use of real-world patient data to study specifically inflammation-related diseases, as the immune system and its complex regulatory network are considered an important driver in determining the balance between health and disease, either through over-activation or dysfunction in activation. Understanding how immune-related diseases are connected by common mechanisms of action will ultimately lead to the development of new diagnostics, innovative therapies and effective tools for personalized medicine.
To this end, LIH’s research focuses specifically on selected priority research areas.
PRIORITY Disease areas
LIH research expertise spans a wide range of disease areas to provide concrete preventative, diagnostic, and therapeutic solutions that are most applicable in the current world, in a bed-to-bench-to-bed approach.
Other Collaborative Disease Areas
LIH research expertise also covers other diseases to provide concrete preventative, diagnostic, and therapeutic solutions that are most applicable in the current world, in a bed-to-bench-to-bed approach.
priority research topics
LIH aims to perform research that transcends the classical boundaries of individual diseases and that can be tangibly applied in the clinical practice to address unmet needs, thus positively affecting health outcomes for patients.
RESEARCH DEPARTMENTS
LIH’s activities are organised around three central research departments, namely the Department of Infection and Immunity (DII), the Department of Cancer Research (DoCR) and the Department of Precision Health (DoPH), with their numerous associated research groups and technological platforms, employing over 200 scientists with complementary expertise in cell and molecular biology, bioinformatics, statistics, clinical research and epidemiology.
